Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / TGTX - TG Therapeutics: Less Room For Doubt About Briumvi

TGTX - TG Therapeutics: Less Room For Doubt About Briumvi

TG Therapeutics Inc.

2024-05-03 09:53:55 ET

Summary

  • TG Therapeutics beat first quarter revenue expectations and raised the full-year revenue guidance by $40 million at the mid-point.
  • Work on the subcutaneous version of Briumvi continues and could represent the next step for increased long-term growth expectations.
  • TG plans to start another clinical trial of Briumvi in a second autoimmune disease and the trial of azer-cel is on track to start this year as well.
  • The first quarter results and the improved outlook leave less room for doubt about Briumvi's growth trajectory.

...

For further details see:

TG Therapeutics: Less Room For Doubt About Briumvi
Stock Information
Company Name: TG Therapeutics Inc.
Stock Symbol: TGTX
Market: NASDAQ
Website: tgtherapeutics.com
Menu
TGTX TGTX Quote TGTX Short TGTX News TGTX Articles TGTX Message Board
Get TGTX Alerts

News, Short Squeeze, Breakout and More Instantly...